Bio-Rad Laboratories (BIO) Accumulated Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Accumulated Expenses for 18 consecutive years, with $150.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 4.63% year-over-year to $150.5 million in Q2 2026; TTM through Jun 2026 was $150.5 million, a 4.63% decrease from a year earlier, with the FY2025 full-year figure at $172.3 million, up 38.73% from the prior year.
• Accumulated Expenses was $150.5 million for Q2 2026 at Bio-Rad Laboratories, up from $148.4 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $194.8 million in Q4 2022 and troughed at $124.2 million in Q4 2024.
• A 5-year average of $160.8 million and a median of $156.2 million in 2023 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses dropped 29.68% in 2022 and surged 38.73% in 2025, its largest moves.
• Over 5 years, Accumulated Expenses stood at $194.8 million in 2022, then retreated by 28.18% to $139.9 million in 2023, then fell by 11.22% to $124.2 million in 2024, then soared by 38.73% to $172.3 million in 2025, then decreased by 12.65% to $150.5 million in 2026.
• The last three Accumulated Expenses figures came in at $150.5 million (Q2 2026), $148.4 million (Q1 2026), and $172.3 million (Q4 2025), per Business Quant data.